www.vascularcures.org

When most people think of heart disease, their association is with coronary artery disease (CAD), where fatty deposits and plaque can build up in the arteries that carry blood from your heart through the body. But artery disease can affect more than just the heart. The limited blood flow caused by artery disease can be dangerous, leading to blood clots and a lesser known but very serious disease called peripheral artery disease (PAD).

CAD is the most common type of heart disease and is the greatest cause of morbidity and mortality in the U.S.1 Approximately 18.2 million adults over age 20 are living with CAD in the U.S.2 PAD affects an estimated 20 million Americans,3 yet only approximately 8.5 million are diagnosed.4 If left untreated, CAD and PAD can increase the risk of serious health outcomes such as heart attack, stroke,5 and – in the case of PAD – acute limb ischemia or even a lower limb amputation.6

It’s important to be aware of the potential connection between these two artery diseases. If you have CAD, you may have an increased risk of PAD – and vice versa.6 In fact, more than 40% of individuals with CAD also have PAD.1

Further, these conditions have overlapping risk factors – including hypertension (high blood pressure), diabetes and smoking (even formerly smoking).6 In fact, smoking is the most common preventable cause of PAD.7 Up to 90 percent of people with PAD have a history of smoking,8 and smokers have a 4x greater risk of PAD than nonsmokers.9

Early detection is key to reducing the chance of serious outcomes. Knowing your risk of CAD and PAD – and talking to your doctor – are important first steps.

Dr. Veita Bland, renowned hypertension specialist and family physician, and Pamela Parker, PAD patient and passionate advocate for artery disease awareness, discusses the importance of early detection, intervention and management of CAD and PAD.

Interview courtesy: Janssen Pharmaceuticals, Inc

IT’S HEARTHEALTH MONTH AND AN IMPORTANT TIME TO TALK ABOUT ARTERY DISEASE.

[ALT, if live or airing before February 1: HEART HEALTH MONTH IS JUST AROUND THE CORNER AND IT’S ANIMPORTANT TIME TO TALK ABOUT ARTERY DISEASE.]

ARTERY DISEASECAN AFFECT MORE THAN JUST YOUR HEART AND EARLY DETECTION IS KEY TO REDUCING THECHANCE OF SERIOUS OUTCOMES.

HERE TO TALKABOUT WHAT YOU NEED TO KNOW ABOUT CORONARY ARTERY DISEASE (C-A-D) AND A RELATEDCONDITION, CALLED PERIPHERAL ARTERY DISEASE (P-A-D), ARE FAMILY PHYSICIAN ANDRENOWNED HYPERTENSION SPECIALIST, DR. VEITA (“Veeta”) BLAND, ALONG WITH P-A-DPATIENT AND ADVOCATE, PAMELA.

BIO’S:

Dr. Veita Bland, Family Physician and Renowned Hypertension Specialist

Dr. Veita Bland is a practicing physician in Greensboro, North Carolina. She is a graduate of Bennett College, Temple University School of Medicine, and the residency program at The University of Maryland. She is board certified in Family Medicine and is a Certified Clinical Hypertension Specialist.

She has spent her career making sure her patients are informed about their health so they understand why taking care of their health is important and can pass down the correct information about their disease to others.

To that end, she is a columnist of medical articles for papers across the country and is the host of the nationally syndicated podcast, “It’s A Matter of Your Health: The30 Min Health Magazine”.

She believes that we all teach each other. So let’s get the information right.

Pam, PAD Patient and Advocate

Pam is a Health and Physical Education Educator in Washington D.C.’s public school system, a heart attack survivor, and a Champion of Women Heart, a non-profit organization that seeks to improve the health and quality of life of women living with or at risk of heart disease.

Pam has educated and empowered others for more than 25 years. She has consistently earned the ranking of Highly Effective Teacher and this year she was honored to be a Physical Education Emerging Leaders (PEEL) Fellowship Candidate. The fellowship builds teacher capacity and establishes schools that serve as a district-wide model of implementing a successful Health and Physical Education program amongst D.C. public schools.

Pam was diagnosed with PAD in 2009, which included immediate surgery to clear blockages in her legs, and suffered a heart attack in 2014. Her experiences led her to advocate in the heart health space. She is passionate about equipping youth –and all of us – with the knowledge and tools to make smart, healthy decisions. Presently, Pam is in the process of writing a children’s book, titled, “I Love My Heart”.

Pam has shared her experiences with Good Morning Washington in 2018 as well as the U.S. House of Representative in 2019. She has spoken at briefings on Capitol Hill, a panel with Vascular Cures and other events engaging lawmakers to inform future health policy.

#veita #bland #pam #vascular #cures #vascularcures #artery #disease #heart #coronary #peripheral #cad #pad #fatty #plaque #blood #diagnosed #janssen #pharmaceuticals #detection

The post Artery Disease Can Affect More Than Just Your Heart appeared first on Good News!.

Raising Awareness About Liver Testing Alternatives
AN EASIER, LESS EXPENSIVE DIAGNOSIS
Non-Invasive Approaches Can Lower Risks and Cut Costs

Hearing that you need a liver biopsy can be worrisome. Yet, many patients undergo an uncomfortable and risky procedure when a less invasive–and less expensive–approach would achieve the same thing, all because they didn’t know that there were other options.

Liver biopsy is risky and invasive. In the case of nonalcoholic fatty liver disease (NAFLD) and its advanced stages of nonalcoholic steatohepatitis (NASH), it can be unreliable and expensive. A typical liver biopsy can cost more than $7,000. For certain patients, advances in technology are offering new, non-invasive ways to get an accurate diagnosis without having to undergo a costly surgical procedure.

Non-invasive diagnostic options include:

● Ultrasound
● Shear Wave Elastography
● MRE (magnetic resonance elastography)

These non-invasive approaches can also mean fewer doctor visits, lower costs, a quicker diagnosis, and no surgical risk. Even so, many are unaware of their options and choose an invasive biopsy procedure due to lack of information.

A new awareness effort aims to change that by educating providers and empowering patients to make choices that will impact their health and their pocketbook.

The post FATTY LIVER Beyond the Biopsy appeared first on Good News!.

WE’RE ALL FOCUSED ON AVOIDING THE CORONAVIRUS, BUT PEOPLE SHOULD NOT NEGLECT THEIR OTHER HEALTH NEEDS. THAT’S BECAUSE UNDERLYING CONDITIONS ARE LINKED TO MORE SEVERE ILLNESS FROM COVID-19. Website: https://www.globalliver.org/
·https://www.fattyliverfoundation.org/
NASH IS ONE OF THE MOST COMMON DISEASES THAT INCREASE YOUR RISK WITHCOVID.
INTERNATIONAL NASH DAY IS JUNE 12TH, DESIGNED TO RAISE AWARENESS OF A TYPE OF PROGRESSIVE LIVER DISEASE THAT AFFECTS ABOUT 20-MILLION AMERICANS.
HERE TO TALK ABOUT INTERNATIONAL NASH DAY, AND THE NEED TO RAISE AWARENESS, ARE WAYNE ESKRIDGE, FOUNDER OFTHE FATTY LIVER FOUNDATION AND CIRRHOSIS PATIENT, ALONG WITH DONNA CRYER, PRESIDENT AND CEO OF THE GLOBAL LIVER INSTITUTE.
BIO-Donna R. Cryer, JD, is the founder and CEO of the Global Liver Institute (GLI), the only patient-driven liver health non-profit operating in the US and Europe. She has channeled her personal experience as an IBD patient and 25-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. Donna is a graduate of Harvard-Radcliffe Colleges and GeorgetownUniversity Law Center.
GLI convenes the NASH Council, LiverCancers Council, International NASH Day(TM), and the Advanced Advocacy Academy, equipping liver patients to be effective advocates. www.globalliver.org @globalliver
BIO-Wayne Eskridge, FattyLiver Foundation President and CEO
Wayne Eskridge, an electrical engineering graduate from the University of Idaho, worked in software and electronics through a 50-year professional career. He served in many technical and managerial roles beginning as a computer programmer, through multiple levels of technical and managerial positions in businesses of all sizes. He held executive positions in both public and private corporations with worldwide responsibilities, and from startups to Fortune 500firms.
In 2015Wayne was diagnosed with stage 4 NASH with cirrhosis. He had no symptoms and didn’t know that his diet, typical of so many Americans, was unhealthy and damaging to his liver. As a result of his own experiences, he became aware of the acute need for educational resources for patients. While there is currently no medical treatment for NAFLD/NASH, lifestyle changes can be effective. Wayne believes that prevention through education is the only practical solution today. His desire to help others avoid his experiences led him to the decision to become a patient champion and to create the Fatty Liver Foundation.

#donna #cryer #wayne #eskridge #nash #non-alcoholic #steatohepatitis #nonalcoholic #international #June #12 #awareness #fatty #liver #disease #impact #prevent #identify #treat #visible #symptoms #common #threatening #medical #health #media #covid #19 #global #institute #social #cancer #foundation #mission #duty #purpose #educate #coordinate #support #victims

The post INTERNATIONAL NASH DAY ON JUNE 12, Fatty Liver Foundation & Global Liver Institute appeared first on Good News!.

The post Visual Guide to Fatty Liver Disease appeared first on Good News!.

Donna R. Cryer, JD, is the founder and CEO of the Global Liver Institute (GLI), the only patient-driven liver health non-profit operating in the US and Europe. She has channeled her personal experience as an IBD patient and 25-year liver transplant recipient into professional advocacy across a career in law, policy, consulting, public relations, clinical trial recruitment, and nonprofit management. Donna is a graduate of Harvard-Radcliffe Colleges and Georgetown University Law Center.

GLI convenes the NASH Council, Liver Cancers Council, International NASH Day(TM),and the Advanced Advocacy Academy, equipping liver patients to be effective advocates.

Wayne Eskridge, Fatty Liver Foundation President and CEO

Wayne Eskridge, an electrical engineering graduate from the University of Idaho, worked in software and electronics through a 50-year professional career. He served in many technical and managerial roles beginning as a computer programmer, through multiple levels of technical and managerial positions in businesses of all sizes. He held executive positions in both public and private corporations with worldwide responsibilities, and from startups to Fortune 500 firms.

In 2015 Wayne was diagnosed with stage 4 NASH with cirrhosis. He had no symptoms and didn’t know that his diet, typical of so many Americans, was unhealthy and damaging to his liver. As a result of his own experiences, he became aware of an acute need for educational resources for patients. While there is currently no medical treatment for NAFLD/NASH, lifestyle changes can be effective. Wayne believes that prevention through education is the only practical solution today. His desire to help others avoid his experiences led him to the decision to become a patient champion and to create the Fatty Liver Foundation.

The post Your Fatty Liver appeared first on Good News!.